Mucolytics for acute exacerbations of chronic obstructive pulmonary …
This meta-analysis explored the safety and effectiveness of mucolytics as an add-on treatment for chronic obstructive pulmonary disease (COPD) exacerbations. Based on a pre-registered protocol and following Cochrane methods, we systematically ...
Mucolytic Medications - StatPearls - NCBI Bookshelf
2023年7月4日 · Mucolytics are drugs used to manage mucus hypersecretion and its sequelae like recurrent infections in patients of COPD, cystic fibrosis, and bronchiectasis. They belong to a group of agents called mucoactive agents.
Role of Mucolytics in the Treatment of Chronic Bronchitis or COPD
2020年7月1日 · Oral mucolytic agents may reduce the number of acute exacerbations in patients with chronic bronchitis or COPD (number needed to treat [NNT] = 8 over an average of nine months; 95% CI, 7 to...
Role of mucolytics in the management of COPD - PMC - PubMed …
2006年1月2日 · Potentially useful mechanisms of action of mucolytics in COPD include: thinning or regulation of production of mucus, promotion of mucociliary clearance and expectoration, and antioxidant or antibacterial activity.
Mucolytic: Agents, Uses, Types, Purpose & Results - Cleveland Clinic
Mucolytics are medications that break up mucus so you can clear it out of your lungs more easily. They’re used to treat cystic fibrosis, bronchiectasis and other lung conditions. They come in oral, intravenous (IV) and nebulizer forms.
Mucolytics: Uses, Side Effects, Dosages, Precautions - Verywell …
2023年3月6日 · Mucolytics are used to treat respiratory conditions such as the common cold, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other conditions marked by excess mucus and a productive (mucus-producing) cough.
Role of mucoactive agents and secretion clearance techniques in COPD
2023年11月16日 · The role of mucoactive therapy in the management of COPD will be reviewed here. The role of mucoactive agents in the treatment of cystic fibrosis (CF) lung disease and non-CF bronchiectasis is discussed separately.
Mucolytic agents for chronic bronchitis or chronic obstructive ...
Mucolytics are medicines taken orally that may loosen sputum, making it easier to cough it up. Mucolytics may have other beneficial effects on lung infection and inflammation and may reduce the number of flare-ups that people with COPD and chronic bronchitis have.
Use of mucolytics in COPD: A Delphi consensus study
Mucolytics are currently recommended as add-on therapy in selected COPD patients. •. Carbocysteine, erdosteine and N-acetylcysteine (NAC) are oral mucolytic agents. •. This Delphi study found consensus among an international panel of COPD experts. •. Findings suggest wider use of mucolytics in treatment of COPD is worth considering. Abstract.
Mucolytics for acute exacerbations of chronic obstructive pulmonary …
2023年1月25日 · This meta-analysis explored the safety and effectiveness of mucolytics as an add-on treatment for chronic obstructive pulmonary disease (COPD) exacerbations.